Apotex Launches At-Risk Generic Plavix
Much to the horror of Bristol-Myers Squibb and Sanofi-Aventis, Apotex officially launched an at-risk generic version of Plavix on Tuesday after the settlement between the three companies over the patent failed...To view the full article, register now.
Already a subscriber? Click here to view full article